These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28554055)

  • 1. Graphene oxide as an efficient antimicrobial nanomaterial for eradicating multi-drug resistant bacteria in vitro and in vivo.
    Wu X; Tan S; Xing Y; Pu Q; Wu M; Zhao JX
    Colloids Surf B Biointerfaces; 2017 Sep; 157():1-9. PubMed ID: 28554055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.
    Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphene-based antibacterial paper.
    Hu W; Peng C; Luo W; Lv M; Li X; Li D; Huang Q; Fan C
    ACS Nano; 2010 Jul; 4(7):4317-23. PubMed ID: 20593851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.
    Prakobsrikul N; Malathum K; Santanirand P; Chumnumwat S; Piebpien P; Montakantikul P
    J Clin Pharm Ther; 2019 Apr; 44(2):292-299. PubMed ID: 30578578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant
    Del Chierico F; Cardile S; Pietrobattista A; Liccardo D; Russo A; Candusso M; Basso MS; Grimaldi C; Pansani L; Bernaschi P; Torre G; Putignani L
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29693574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control.
    Bassetti M; Righi E; Carnelutti A; Graziano E; Russo A
    Expert Rev Anti Infect Ther; 2018 Oct; 16(10):749-761. PubMed ID: 30207815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model.
    Tan S; Gan C; Li R; Ye Y; Zhang S; Wu X; Yang YY; Fan W; Wu M
    Int J Nanomedicine; 2015; 10():1045-59. PubMed ID: 25709431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal effect of graphene oxide/Cu/Ag nanoderivatives against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
    JankauskaitĿ V; VitkauskienĿ A; Lazauskas A; Baltrusaitis J; ProsyĿevas I; AndruleviĿius M
    Int J Pharm; 2016 Sep; 511(1):90-97. PubMed ID: 27370911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial physiology is a key modulator of the antibacterial activity of graphene oxide.
    Karahan HE; Wei L; Goh K; Liu Z; Birer Ö; Dehghani F; Xu C; Wei J; Chen Y
    Nanoscale; 2016 Oct; 8(39):17181-17189. PubMed ID: 27722381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria.
    Yousefi M; Dadashpour M; Hejazi M; Hasanzadeh M; Behnam B; de la Guardia M; Shadjou N; Mokhtarzadeh A
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():568-581. PubMed ID: 28254332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China.
    Zhang Y; Yang J; Ye L; Luo Y; Wang W; Zhou W; Cui Z; Han L
    Microb Drug Resist; 2012 Oct; 18(5):465-70. PubMed ID: 22548669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.